HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

5- chloro- 2- (5- chlorothiophene- 2- sulfonylamino)- N- (4- (morpholine- 4- sulfonyl)phenyl)benzamide

a soluble guanylyl cyclase activator; structure in first source
Also Known As:
HMR 1766; HMR-1766; HMR1766; ataciguat; Benzamide, 5-chloro-2-(((5-chloro-2-thienyl)sulfonyl)amino)-N-(4-(4-morpholinylsulfonyl)phenyl)-
Networked: 8 relevant articles (2 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Bauersachs, Johann: 2 articles (07/2014 - 11/2010)
2. Fraccarollo, Daniela: 2 articles (07/2014 - 11/2010)
3. Schäfer, Andreas: 2 articles (07/2014 - 11/2010)
4. Agulló, Luis: 1 article (09/2014)
5. Fernández, Celia: 1 article (09/2014)
6. Garcia-Dorado, David: 1 article (09/2014)
7. Hernando, Víctor: 1 article (09/2014)
8. Inserte, Javier: 1 article (09/2014)
9. Poncelas-Nozal, Marcos: 1 article (09/2014)
10. Ruiz-Meana, Marisol: 1 article (09/2014)

Related Diseases

1. Hypoxia (Hypoxemia)
2. Pulmonary Edema
3. Infarction (Infarctions)
4. Heart Failure
5. Cardiovascular Diseases (Cardiovascular Disease)

Related Drugs and Biologics

1. Soluble Guanylyl Cyclase
2. Heme (Haem)
3. Guanylate Cyclase (Guanylyl Cyclase)
4. BAY 58-2667
5. Nitric Oxide (Nitrogen Monoxide)
6. Albumins
7. 3- (2- (2,2- dimethylpropylsulfanyl)pyridin- 3- yl)- N- (3- hydroxycyclohexyl)acrylamide

Related Therapies and Procedures

1. Therapeutics